MedTrace Logo

"Night Vision and Carotenoids"

NCT04741763 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2021-02-05

No results posted yet for this study

Summary

Vision at twilight and night is more difficult and dangerous for the entire population, even more so for the elderly and especially for the elderly with degenerative disease. Multiple worldwide laboratories have demonstrated the ability to raise macular pigment optical density with dietary carotenoids. This proposal further evaluates the relationship between macular re- pigmentation and vision under stressed conditions simulating twilight and night driving.

Conditions

  • Macular Degeneration

Interventions

DIETARY_SUPPLEMENT

EyePromise Visual Edge

A dietary eye supplement containing 8 mg zeaxanthin and 4 mg lutein and additional proprietary nutrients

Sponsors & Collaborators

  • Davis EyeCare

    collaborator OTHER

  • Robert Davis

    lead OTHER

Principal Investigators

  • Steven Novil, PhD, ND · Optometry Research Lab manager, Optometry Clinic- Captain James A Lovell FHCC

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-13
Primary Completion
2019-08-20
Completion
2020-08-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04741763 on ClinicalTrials.gov